Position in CBLL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$359,707
+$142,403 QoQ
Shares Held
19,624
+98.0% QoQ
Ownership
0.052%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
4 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CBLL Over Time
Shares Held
Position Value (USD)
Derivatives in CBLL
reported options exposure · as of Mar 31, 2026CallValue
$0
CallShares
0
PutValue
$351,936
PutShares
19,200
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Medical Devices
Healthcare · as of Mar 31, 2026SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $313,124,743 across 83 Medical Devices names. CBLL ranks #49 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
720,999 | $74,024,967 | |
| 2 | BSX |
Boston Scientific Corp
|
1,033,109 | $64,827,589 | |
| 3 | DXCM |
Dexcom Inc
|
378,706 | $23,782,736 | |
| 4 | PEN |
Penumbra Inc
|
45,531 | $14,951,014 | |
| 5 | TMDX |
TransMedics Group, Inc.
|
133,875 | $13,308,513 | |
| 6 | HAE |
Haemonetics Corp
|
234,271 | $13,203,513 | |
| 7 | INSP |
Inspire Medical Systems, Inc.
|
210,573 | $10,861,355 | |
| 8 | EW |
Edwards Lifesciences Corp
|
119,419 | $9,563,073 |
All Filings in CBLL
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $351,936 | 19,200 | Put | Other | 2026-05-15 | |
| 2026-03-31 | $359,707 | 19,624 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $217,304 | 9,909 | Shares | Other | 2026-02-17 | |
| 2025-06-30 | $559,221 | 29,857 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $320,173 | 16,667 | Shares | Other | 2025-05-14 | |
| No filing history on record for this holder in this stock. | ||||||